19-7745631-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021155.4(CD209):c.635A>T(p.Gln212Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000934 in 115,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021155.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD209 | NM_021155.4 | c.635A>T | p.Gln212Leu | missense_variant | 4/7 | ENST00000315599.12 | NP_066978.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD209 | ENST00000315599.12 | c.635A>T | p.Gln212Leu | missense_variant | 4/7 | 1 | NM_021155.4 | ENSP00000315477.6 | ||
ENSG00000288669 | ENST00000678003.1 | n.32A>T | non_coding_transcript_exon_variant | 1/13 | ENSP00000504497.1 |
Frequencies
GnomAD3 genomes AF: 0.000908 AC: 105AN: 115598Hom.: 0 Cov.: 27
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000128 AC: 6AN: 470530Hom.: 0 Cov.: 0 AF XY: 0.0000158 AC XY: 4AN XY: 253326
GnomAD4 genome AF: 0.000934 AC: 108AN: 115654Hom.: 0 Cov.: 27 AF XY: 0.000897 AC XY: 50AN XY: 55760
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.635A>T (p.Q212L) alteration is located in exon 4 (coding exon 4) of the CD209 gene. This alteration results from a A to T substitution at nucleotide position 635, causing the glutamine (Q) at amino acid position 212 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at